
Publikationen von Martin A. Kohli
Alle Typen
Zeitschriftenartikel (22)
1.
Zeitschriftenartikel
95, 109686 (2019)
Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2.
Zeitschriftenartikel
18 (2), S. 199 - 209 (2015)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. NATURE NEUROSCIENCE 3.
Zeitschriftenartikel
37 (4), S. 565 - 575 (2012)
Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology 4.
Zeitschriftenartikel
106 (8), S. 1263 - 1272 (2011)
Gene-PUFA interactions and obesity risk. British Journal of Nutrition 5.
Zeitschriftenartikel
44 (6), S. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 6.
Zeitschriftenartikel
16 (6), S. 647 - 663 (2011)
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 7.
Zeitschriftenartikel
69 (9 Suppl.1), S. 152 S - 152 S (2011)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 8.
Zeitschriftenartikel
15 (7), S. 736 - 747 (2010)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 9.
Zeitschriftenartikel
67 (9 Suppl.1), S. 127S - 128S (2010)
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 10.
Zeitschriftenartikel
67 (4), S. 348 - 359 (2010)
Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 11.
Zeitschriftenartikel
73, S. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 12.
Zeitschriftenartikel
66 (9), S. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 13.
Zeitschriftenartikel
42 (5), S. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 14.
Zeitschriftenartikel
42 (5), S. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 15.
Zeitschriftenartikel
42 (5), S. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 16.
Zeitschriftenartikel
18 (Suppl. 4), S. S296 - S296 (2008)
Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 17.
Zeitschriftenartikel
57, S. 203 - 209 (2008)
Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 18.
Zeitschriftenartikel
105, S. 177 - 184 (2008)
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of Affective Disorders 19.
Zeitschriftenartikel
40 (5), S. 212 - 212 (2007)
SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 20.
Zeitschriftenartikel
40 (5), S. 212 - 212 (2007)
Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data. Pharmacopsychiatry